Unravelling the Link between Psychological Distress and Liver Disease: Insights from an Anxiety-like Rat Model and Metabolomics Analysis
Abstract
:1. Introduction
2. Results
2.1. Composite Stress-Induced Anxiety-like Behaviors in Rats
2.2. Anxiety-like Behavior Aggravated Liver Injury
2.3. Hepatic Metabolomic Analysis of Rats with Anxiety-like Behavior
2.4. Anxiety-like Behavior Aggravated Liver Injury through the EGFR Pathway
2.5. Liver Injury Resulted in the Formation of Inflammatory Factors
3. Discussion
4. Methods and Materials
4.1. Chemicals and Reagents
4.2. Animals and Grouping
4.3. Open Field Test (OFT)
4.4. Elevated Plus Maze (EPM) Test
4.5. Forced Swimming Test (FST)
4.6. Sucrose Preference Test (SPT)
4.7. Sample Preparation for LC-MS
4.8. LC-MS Non-Targeted Analysis
4.9. Identification of Metabolites and Pathway Analysis
4.10. Hematoxylin and Eosin Staining (H&E), Immunohistochemistry (IHC), and Immunofluorescence (IF)
4.11. Western Blotting Assay
4.12. Real-Time PCR Analysis
4.13. Statistical Analysis
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- De Figueiredo, C.S.; Sandre, P.C.; Portugal, L.C.L.; Mázala-de-Oliveira, T.; da Silva Chagas, L.; Raony, Í.; Ferreira, E.S.; Giestal-de-Araujo, E.; Dos Santos, A.A.; Bomfim, P.O. COVID-19 pandemic impact on children and adolescents’ mental health: Biological, environmental, and social factors. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2021, 106, 110171. [Google Scholar] [CrossRef] [PubMed]
- Koenig, J.; Kohls, E.; Moessner, M.; Lustig, S.; Bauer, S.; Becker, K.; Thomasius, R.; Eschenbeck, H.; Diestelkamp, S.; Gillé, V.; et al. The impact of COVID-19 related lockdown measures on self-reported psychopathology and health-related quality of life in German adolescents. Eur. Child Adolesc. Psychiatry 2023, 32, 113–122. [Google Scholar] [CrossRef] [PubMed]
- Lai, H.M.; Cleary, M.; Sitharthan, T.; Hunt, G.E. Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: A systematic review and meta-analysis. Drug Alcohol Depend. 2015, 154, 1–13. [Google Scholar] [CrossRef] [PubMed]
- Barić, H.; Đorđević, V.; Cerovečki, I.; Trkulja, V. Complementary and Alternative Medicine Treatments for Generalized Anxiety Disorder: Systematic Review and Meta-analysis of Randomized Controlled Trials. Adv. Ther. 2018, 35, 261–288. [Google Scholar] [CrossRef]
- Bandelow, B.; Michaelis, S. Epidemiology of anxiety disorders in the 21st century. Dialogues Clin. Neurosci. 2015, 17, 327–335. [Google Scholar] [CrossRef]
- Wieckiewicz, M.; Danel, D.; Pondel, M.; Smardz, J.; Martynowicz, H.; Wieczorek, T.; Mazur, G.; Pudlo, R.; Wieckiewicz, G. Identification of risk groups for mental disorders, headache and oral behaviors in adults during the COVID-19 pandemic. Sci. Rep. 2021, 11, 10964. [Google Scholar] [CrossRef]
- Auerbach, R.P.; Mortier, P.; Bruffaerts, R.; Alonso, J.; Benjet, C.; Cuijpers, P.; Demyttenaere, K.; Ebert, D.D.; Green, J.G.; Hasking, P.; et al. WHO World Mental Health Surveys International College Student Project: Prevalence and distribution of mental disorders. J. Abnorm. Psychol. 2018, 127, 623–638. [Google Scholar] [CrossRef]
- Dalsgaard, S.; Thorsteinsson, E.; Trabjerg, B.B.; Schullehner, J.; Plana-Ripoll, O.; Brikell, I.; Wimberley, T.; Thygesen, M.; Madsen, K.B.; Timmerman, A.; et al. Incidence Rates and Cumulative Incidences of the Full Spectrum of Diagnosed Mental Disorders in Childhood and Adolescence. JAMA Psychiatry 2020, 77, 155–164. [Google Scholar] [CrossRef]
- Chalmers, J.A.; Quintana, D.S.; Abbott, M.J.; Kemp, A.H. Anxiety Disorders are Associated with Reduced Heart Rate Variability: A Meta-Analysis. Front. Psychiatry 2014, 5, 80. [Google Scholar] [CrossRef]
- Russ, T.C.; Stamatakis, E.; Hamer, M.; Starr, J.M.; Kivimäki, M.; Batty, G.D. Association between psychological distress and mortality: Individual participant pooled analysis of 10 prospective cohort studies. BMJ 2012, 345, e4933. [Google Scholar] [CrossRef]
- Vere, C.C.; Streba, C.T.; Streba, L.M.; Ionescu, A.G.; Sima, F. Psychosocial stress and liver disease status. World J. Gastroenterol. 2009, 15, 2980–2986. [Google Scholar] [CrossRef] [PubMed]
- Wang, Y.S.; Shen, C.Y.; Jiang, J.G. Antidepressant active ingredients from herbs and nutraceuticals used in TCM: Pharmacological mechanisms and prospects for drug discovery. Pharmacol. Res. 2019, 150, 104520. [Google Scholar] [CrossRef] [PubMed]
- Zheng, J.; Zheng, Y.; Li, W.; Zhi, J.; Huang, X.; Zhu, W.; Liu, Z.; Gong, L. Combined metabolomics with transcriptomics reveals potential plasma biomarkers correlated with non-small-cell lung cancer proliferation through the Akt pathway. Clin. Chim. Acta Int. J. Clin. Chem. 2022, 530, 66–73. [Google Scholar] [CrossRef]
- Sartori, S.B.; Singewald, N. Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders. Pharmacol. Ther. 2019, 204, 107402. [Google Scholar] [CrossRef] [PubMed]
- Kumar, N.; Shahjaman, M.; Mollah, M.N.H.; Islam, S.M.S.; Hoque, M.A. Serum and Plasma Metabolomic Biomarkers for Lung Cancer. Bioinformation 2017, 13, 202–208. [Google Scholar] [CrossRef] [PubMed]
- Callejón-Leblic, B.; García-Barrera, T.; Grávalos-Guzmán, J.; Pereira-Vega, A.; Gómez-Ariza, J.L. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/gas chromatography mass spectrometry platform. J. Proteom. 2016, 145, 197–206. [Google Scholar] [CrossRef]
- Naz, S.; Moreira dos Santos, D.C.; García, A.; Barbas, C. Analytical protocols based on LC-MS, GC-MS and CE-MS for nontargeted metabolomics of biological tissues. Bioanalysis 2014, 6, 1657–1677. [Google Scholar] [CrossRef]
- Miller, W.L. The Hypothalamic-Pituitary-Adrenal Axis: A Brief History. Horm. Res. Paediatr. 2018, 89, 212–223. [Google Scholar] [CrossRef]
- Malakouti, M.; Kataria, A.; Ali, S.K.; Schenker, S. Elevated Liver Enzymes in Asymptomatic Patients—What Should I Do? J. Clin. Transl. Hepatol. 2017, 5, 394–403. [Google Scholar] [CrossRef]
- Fan, X.; Childs, G.V. Epidermal growth factor and transforming growth factor-alpha messenger ribonucleic acids and their receptors in the rat anterior pituitary: Localization and regulation. Endocrinology 1995, 136, 2284–2293. [Google Scholar] [CrossRef]
- Kivimäki, M.; Steptoe, A. Effects of stress on the development and progression of cardiovascular disease. Nat. Rev. Cardiol. 2018, 15, 215–229. [Google Scholar] [CrossRef] [PubMed]
- Sur, B.; Lee, B. Myricetin Inhibited Fear and Anxiety-Like Behaviors by HPA Axis Regulation and Activation of the BDNF-ERK Signaling Pathway in Posttraumatic Stress Disorder Rats. Evid.-Based Complement. Altern. Med. eCAM 2022, 2022, 8320256. [Google Scholar] [CrossRef] [PubMed]
- Kong, L.; Zhang, D.; Huang, S.; Lai, J.; Lu, L.; Zhang, J.; Hu, S. Extracellular Vesicles in Mental Disorders: A State-of-art Review. Int. J. Biol. Sci. 2023, 19, 1094–1109. [Google Scholar] [CrossRef]
- Komposch, K.; Sibilia, M. EGFR Signaling in Liver Diseases. Int. J. Mol. Sci. 2015, 17, 30. [Google Scholar] [CrossRef]
- McNulty, H.; Strain, J.J.; Hughes, C.F.; Ward, M. Riboflavin, MTHFR genotype and blood pressure: A personalized approach to prevention and treatment of hypertension. Mol. Asp. Med. 2017, 53, 2–9. [Google Scholar] [CrossRef]
- Trujillo-Gonzalez, I.; Wang, Y.; Friday, W.B.; Vickers, K.C.; Toth, C.L.; Molina-Torres, L.; Surzenko, N.; Zeisel, S.H. MicroRNA-129-5p is regulated by choline availability and controls EGF receptor synthesis and neurogenesis in the cerebral cortex. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 2019, 33, 3601–3612. [Google Scholar] [CrossRef]
- Riaza Bermudo-Soriano, C.; Perez-Rodriguez, M.M.; Vaquero-Lorenzo, C.; Baca-Garcia, E. New perspectives in glutamate and anxiety. Pharmacol. Biochem. Behav. 2012, 100, 752–774. [Google Scholar] [CrossRef]
- Mahdavifar, B.; Hosseinzadeh, M.; Salehi-Abargouei, A.; Mirzaei, M.; Vafa, M. Dietary intake of B vitamins and their association with depression, anxiety, and stress symptoms: A cross-sectional, population-based survey. J. Affect. Disord. 2021, 288, 92–98. [Google Scholar] [CrossRef]
- Di Meo, S.; Reed, T.T.; Venditti, P.; Victor, V.M. Role of ROS and RNS Sources in Physiological and Pathological Conditions. Oxidative Med. Cell. Longev. 2016, 2016, 1245049. [Google Scholar] [CrossRef]
- Schlessinger, J. Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell 2002, 110, 669–672. [Google Scholar] [CrossRef]
- Jorissen, R.N.; Walker, F.; Pouliot, N.; Garrett, T.P.; Ward, C.W.; Burgess, A.W. Epidermal growth factor receptor: Mechanisms of activation and signalling. Exp. Cell Res. 2003, 284, 31–53. [Google Scholar] [CrossRef] [PubMed]
- Seshacharyulu, P.; Ponnusamy, M.P.; Haridas, D.; Jain, M.; Ganti, A.K.; Batra, S.K. Targeting the EGFR signaling pathway in cancer therapy. Expert Opin. Ther. Targets 2012, 16, 15–31. [Google Scholar] [CrossRef]
- Michalopoulos, G.K.; Bhushan, B. Liver regeneration: Biological and pathological mechanisms and implications. Nat. Rev. Gastroenterol. Hepatol. 2021, 18, 40–55. [Google Scholar] [CrossRef] [PubMed]
- Berasain, C.; Avila, M.A. The EGFR signalling system in the liver: From hepatoprotection to hepatocarcinogenesis. J. Gastroenterol. 2014, 49, 9–23. [Google Scholar] [CrossRef] [PubMed]
- Karaman, B.; Battal, B.; Sari, S.; Verim, S. Hepatocellular carcinoma review: Current treatment, and evidence-based medicine. World J. Gastroenterol. 2014, 20, 18059–18060. [Google Scholar] [CrossRef]
- Fuchs, B.C.; Hoshida, Y.; Fujii, T.; Wei, L.; Yamada, S.; Lauwers, G.Y.; McGinn, C.M.; DePeralta, D.K.; Chen, X.; Kuroda, T.; et al. Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma. Hepatology 2014, 59, 1577–1590. [Google Scholar] [CrossRef]
- Zeboudj, L.; Maître, M.; Guyonnet, L.; Laurans, L.; Joffre, J.; Lemarie, J.; Bourcier, S.; Nour-Eldine, W.; Guérin, C.; Friard, J.; et al. Selective EGF-Receptor Inhibition in CD4(+) T Cells Induces Anergy and Limits Atherosclerosis. J. Am. Coll. Cardiol. 2018, 71, 160–172. [Google Scholar] [CrossRef]
- Himeno, A.; Satoh-Asahara, N.; Usui, T.; Wada, H.; Tochiya, M.; Kono, S.; Yamada-Goto, N.; Katsuura, G.; Hasegawa, K.; Nakao, K.; et al. Salivary cortisol levels are associated with outcomes of weight reduction therapy in obese Japanese patients. Metab. Clin. Exp. 2012, 61, 255–261. [Google Scholar] [CrossRef]
- Mitsudomi, T.; Yatabe, Y. Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer. FEBS J. 2010, 277, 301–308. [Google Scholar] [CrossRef]
- Steelman, L.S.; Chappell, W.H.; Abrams, S.L.; Kempf, R.C.; Long, J.; Laidler, P.; Mijatovic, S.; Maksimovic-Ivanic, D.; Stivala, F.; Mazzarino, M.C.; et al. Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. Aging 2011, 3, 192–222. [Google Scholar] [CrossRef]
- Yu, M.; Qi, B.; Xiaoxiang, W.; Xu, J.; Liu, X. Baicalein increases cisplatin sensitivity of A549 lung adenocarcinoma cells via PI3K/Akt/NF-κB pathway. Biomed. Pharmacother. Biomed. Pharmacother. 2017, 90, 677–685. [Google Scholar] [CrossRef] [PubMed]
- Wang, J.; Hu, K.; Cai, X.; Yang, B.; He, Q.; Wang, J.; Weng, Q. Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis. Acta Pharm. Sin. B 2022, 12, 18–32. [Google Scholar] [CrossRef] [PubMed]
- Burow, M.E.; Weldon, C.B.; Melnik, L.I.; Duong, B.N.; Collins-Burow, B.M.; Beckman, B.S.; McLachlan, J.A. PI3-K/AKT regulation of NF-kappaB signaling events in suppression of TNF-induced apoptosis. Biochem. Biophys. Res. Commun. 2000, 271, 342–345. [Google Scholar] [CrossRef]
- Shea, S.; Lionis, C.; Kite, C.; Atkinson, L.; Chaggar, S.S.; Randeva, H.S.; Kyrou, I. Non-Alcoholic Fatty Liver Disease (NAFLD) and Potential Links to Depression, Anxiety, and Chronic Stress. Biomedicines 2021, 9, 1697. [Google Scholar] [CrossRef]
- Orrù, M.G.; Pariante, C.M. Depression and liver diseases. Dig. Liver Dis. Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver 2005, 37, 564–565. [Google Scholar] [CrossRef]
- Seibenhener, M.L.; Wooten, M.C. Use of the Open Field Maze to measure locomotor and anxiety-like behavior in mice. J. Vis. Exp. JOVE 2015, 96, e52434. [Google Scholar] [CrossRef]
- Grivas, V.; Markou, A.; Pitsikas, N. The metabotropic glutamate 2/3 receptor agonist LY379268 induces anxiety-like behavior at the highest dose tested in two rat models of anxiety. Eur. J. Pharmacol. 2013, 715, 105–110. [Google Scholar] [CrossRef]
- Casarrubea, M.; Faulisi, F.; Sorbera, F.; Crescimanno, G. The effects of different basal levels of anxiety on the behavioral shift analyzed in the central platform of the elevated plus maze. Behav. Brain Res. 2015, 281, 55–61. [Google Scholar] [CrossRef]
- Van Bodegom, M.; Homberg, J.R.; Henckens, M. Modulation of the Hypothalamic-Pituitary-Adrenal Axis by Early Life Stress Exposure. Front. Cell. Neurosci. 2017, 11, 87. [Google Scholar] [CrossRef]
- He, T.; Guo, C.; Wang, C.; Hu, C.; Chen, H. Effect of early life stress on anxiety and depressive behaviors in adolescent mice. Brain Behav. 2020, 10, e01526. [Google Scholar] [CrossRef]
- Franceschi Biagioni, A.; Cellot, G.; Pati, E.; Lozano, N.; Ballesteros, B.; Casani, R.; Coimbra, N.C.; Kostarelos, K.; Ballerini, L. Graphene oxide prevents lateral amygdala dysfunctional synaptic plasticity and reverts long lasting anxiety behavior in rats. Biomaterials 2021, 271, 120749. [Google Scholar] [CrossRef] [PubMed]
- Slattery, D.A.; Cryan, J.F. Using the rat forced swim test to assess antidepressant-like activity in rodents. Nat. Protoc. 2012, 7, 1009–1014. [Google Scholar] [CrossRef] [PubMed]
- Czéh, B.; Fuchs, E.; Wiborg, O.; Simon, M. Animal models of major depression and their clinical implications. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2016, 64, 293–310. [Google Scholar] [CrossRef]
- Xu, R.; Liang, J.; Cheng, M.; Wu, H.; Wu, H.; Cao, S.; Zhao, W.; Xu, R.; Zhou, A. Liver and urine metabolomics reveal the protective effect of Gandou decoction in copper-laden Hepatolenticular degeneration model rats. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2021, 1179, 122844. [Google Scholar] [CrossRef] [PubMed]
- Ramos-Vara, J.A. Principles and Methods of Immunohistochemistry. Methods Mol. Biol. 2017, 1641, 115–128. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Liu, B.; Zhang, S.; Sun, L.; Huang, L.; Zhang, R.; Liu, Z.; An, L. Unravelling the Link between Psychological Distress and Liver Disease: Insights from an Anxiety-like Rat Model and Metabolomics Analysis. Int. J. Mol. Sci. 2023, 24, 13356. https://doi.org/10.3390/ijms241713356
Liu B, Zhang S, Sun L, Huang L, Zhang R, Liu Z, An L. Unravelling the Link between Psychological Distress and Liver Disease: Insights from an Anxiety-like Rat Model and Metabolomics Analysis. International Journal of Molecular Sciences. 2023; 24(17):13356. https://doi.org/10.3390/ijms241713356
Chicago/Turabian StyleLiu, Binjie, Shanshan Zhang, Lizhu Sun, Lan Huang, Rong Zhang, Zhongqiu Liu, and Lin An. 2023. "Unravelling the Link between Psychological Distress and Liver Disease: Insights from an Anxiety-like Rat Model and Metabolomics Analysis" International Journal of Molecular Sciences 24, no. 17: 13356. https://doi.org/10.3390/ijms241713356